Novel EX-vivo immunoadsorption therapy to treat preeclampsia
Ended Project Grant Awarded Last action
- Award ID
- R44HD075571
- Recipient
-
Aggamin Pharmaceuticals LLC UEI E21PRNABGN38
- Awarding agency
-
National Institutes of Health
Department of Health and Human Services
- Obligated
- $1,243,090
Award facts
- Assistance listing
- 93.865 Child Health and Human Development Extramural Research
- Completion date
- Originally
- Place of performance
- New York, NY 10032, USA
Award details come from USAspending.gov.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | $0 | |
| Amendment | $623,844 | |
| Original award | $619,246 |
Quick answers
Who received award R44HD075571?
R44HD075571 was awarded to Aggamin Pharmaceuticals LLC by National Institutes of Health (Department of Health and Human Services) on December 1, 2012.
How much is award R44HD075571 worth?
$1,243,090 has been obligated on R44HD075571.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award